Variant report

Variant	esv15094
Chromosome Location	chr14:36986331-36990958
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr14:36989745-36989957	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr14:36986448-36986648	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr14:36990812-36991136	IMR90	lung:	n/a	n/a
4	CEBPB	chr14:36990800-36991121	A549	lung:	n/a	n/a
5	CEBPB	chr14:36990811-36991121	K562	blood:	n/a	n/a
6	CEBPB	chr14:36990786-36991165	HepG2	liver:	n/a	n/a
7	CEBPB	chr14:36990780-36991208	H1-hESC	embryonic stem cell:	n/a	n/a
8	CEBPB	chr14:36989944-36989976	H1-hESC	embryonic stem cell:	n/a	n/a
9	CEBPB	chr14:36990788-36991152	HepG2	liver:	n/a	n/a
10	CEBPB	chr14:36990844-36991067	HepG2	liver:	n/a	n/a
11	CEBPB	chr14:36989884-36990055	HepG2	liver:	n/a	n/a
12	CEBPB	chr14:36990887-36991084	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr14:36990830-36991092	K562	blood:	n/a	n/a
14	CHD1	chr14:36986475-36986486	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD1	chr14:36990227-36990245	H1-hESC	embryonic stem cell:	n/a	n/a
16	CHD2	chr14:36989086-36989413	H1-hESC	embryonic stem cell:	n/a	n/a
17	CHD2	chr14:36989868-36990044	HepG2	liver:	n/a	chr14:36989894-36989904
18	CTBP2	chr14:36985797-36986843	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTBP2	chr14:36987100-36990550	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr14:36989880-36990030	SAEC	small airway:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
21	CTCF	chr14:36989860-36990010	A549	lung:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
22	CTCF	chr14:36989184-36990314	A549	lung:	n/a	chr14:36989542-36989555 chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
23	CTCF	chr14:36989919-36990040	GM10266	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
24	CTCF	chr14:36989840-36990095	MCF-7	breast:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
25	CTCF	chr14:36989860-36990010	HA-sp	spinal cord:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
26	CTCF	chr14:36989840-36989990	HRE	kidney:	n/a	chr14:36989958-36989971
27	CTCF	chr14:36989880-36990030	HEEpiC	esophagus:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
28	CTCF	chr14:36989860-36990010	HCT-116	colon:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
29	CTCF	chr14:36989900-36990050	GM12871	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
30	CTCF	chr14:36989900-36990050	Hela-S3	cervix:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
31	CTCF	chr14:36989400-36989550	Caco-2	colon:	n/a	n/a
32	CTCF	chr14:36989900-36990050	HUVEC	blood vessel:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
33	CTCF	chr14:36989960-36990110	GM12865	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991
34	CTCF	chr14:36989940-36990090	HL-60	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
35	CTCF	chr14:36989360-36989510	NHEK	skin:	n/a	n/a
36	CTCF	chr14:36989855-36990139	H1-hESC	embryonic stem cell:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
37	CTCF	chr14:36989890-36990067	GM19238	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
38	CTCF	chr14:36989980-36990130	HFF-Myc	foreskin:	n/a	n/a
39	CTCF	chr14:36989860-36990010	AoAF	blood vessel:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
40	CTCF	chr14:36989856-36990055	Fibrobl	skin:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
41	CTCF	chr14:36990765-36991200	H1-hESC	embryonic stem cell:	n/a	n/a
42	CTCF	chr14:36989360-36989510	Caco-2	colon:	n/a	n/a
43	CTCF	chr14:36989920-36990070	SAEC	small airway:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
44	CTCF	chr14:36989900-36990050	GM12878	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
45	CTCF	chr14:36989840-36989990	HPF	lung:	n/a	chr14:36989958-36989971
46	CTCF	chr14:36989883-36990083	GM12878	blood:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
47	CTCF	chr14:36989920-36990070	HMEC	breast:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
48	CTCF	chr14:36989880-36990030	HBMEC	blood vessel:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971
49	CTCF	chr14:36988660-36988810	A549	lung:	n/a	n/a
50	CTCF	chr14:36989880-36990030	HFF-Myc	foreskin:	n/a	chr14:36989974-36989992 chr14:36989975-36989991 chr14:36989958-36989971

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:36989290-36989340	PFSK-1	brain:	n/a
2	chr14:36989290-36989340	PFSK-1	brain:	n/a
3	chr14:36990430-36990480	HEEpiC	esophagus:	n/a
4	chr14:36990534-36990584	GM19239	blood:	n/a
5	chr14:36987301-36987351	AG10803	skin:	n/a
6	chr14:36988805-36988855	ProgFib	skin:	n/a
7	chr14:36989287-36989337	ProgFib	skin:	n/a
8	chr14:36990430-36990480	PANC-1	pancreas:	n/a
9	chr14:36989550-36989600	HEK293	kidney:	embryo
10	chr14:36988443-36988493	GM19239	blood:	n/a
11	chr14:36988217-36988267	HepG2	liver:	n/a
12	chr14:36989287-36989337	PFSK-1	brain:	n/a
13	chr14:36988217-36988267	HEK293	kidney:	embryo
14	chr14:36987722-36987772	ECC-1	luminal epithelium:	n/a
15	chr14:36989922-36989972	HRE	kidney:	n/a
16	chr14:36989454-36989504	RPTEC	kidney:	n/a
17	chr14:36990144-36990194	HRCEpiC	kidney:	n/a
18	chr14:36990144-36990194	SK-N-SH	brain:	n/a
19	chr14:36986363-36986413	NB4	blood:	n/a
20	chr14:36990534-36990584	HNPCEpiC	eye:	n/a
21	chr14:36989287-36989337	NHDF-neo	bronchial:	n/a
22	chr14:36989287-36989337	AoSMC	blood vessel:	n/a
23	chr14:36987301-36987351	MCF10A-Er-Src	breast:	n/a
24	chr14:36990144-36990194	Hepatocyte	liver:	n/a
25	chr14:36988805-36988855	HMEC	breast:	n/a
26	chr14:36986363-36986413	IMR90	lung:	fetal
27	chr14:36989290-36989340	MCF-7	breast:	n/a
28	chr14:36988446-36988496	HL-60	blood:	n/a
29	chr14:36988217-36988267	LNCaP	prostate:	n/a
30	chr14:36989922-36989972	ECC-1	luminal epithelium:	n/a
31	chr14:36987722-36987772	NB4	blood:	n/a
32	chr14:36987408-36987458	HEK293	kidney:	embryo
33	chr14:36989454-36989504	ECC-1	luminal epithelium:	n/a
34	chr14:36988446-36988496	HAEpiC	amniotic membrane:	n/a
35	chr14:36987408-36987458	AG04450	lung:	fetal
36	chr14:36989850-36989900	BE2_C	brain:	n/a
37	chr14:36990534-36990584	Caco-2	colon:	n/a
38	chr14:36988805-36988855	HRCEpiC	kidney:	n/a
39	chr14:36988778-36988828	Jurkat	blood:	n/a
40	chr14:36990534-36990584	HCT-116	colon:	n/a
41	chr14:36989588-36989638	HPAEpiC	pulmonary alveolar:	n/a
42	chr14:36988217-36988267	NT2-D1	testis:	n/a
43	chr14:36986585-36986635	U87	brain:	n/a
44	chr14:36989922-36989972	AG04449	skin:	fetal
45	chr14:36989454-36989504	K562	blood:	n/a
46	chr14:36989404-36989454	HRPEpiC	eye:	n/a
47	chr14:36989922-36989972	NB4	blood:	n/a
48	chr14:36989922-36989972	HNPCEpiC	eye:	n/a
49	chr14:36989850-36989900	HAEpiC	amniotic membrane:	n/a
50	chr14:36987408-36987458	BE2_C	brain:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr14:36986593..36988111-chr14:36992508..36994903,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SFTA3-1	chr14:36988673-36988726	ENSG00000257520.1
2	lnc-PAX9-3	chr14:36990849-36992221	ENSG00000253563.2
3	lnc-PAX9-3	chr14:36988483-36988884	ENSG00000253563.2

Variant related genes	Relation type
SFTA3	TF binding region
NKX2-1	TF binding region
ENSG00000257520	TF binding region
NKX2-1-AS1	TF binding region
SFTA3	CpG island
NKX2-1	CpG island
ENSG00000257520	CpG island
NKX2-1-AS1	CpG island

Extended variants
information (count: 171 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:171 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs377039468	chr14:36986333-36986334	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs564521320	chr14:36986340-36986341	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs533460253	chr14:36986341-36986342	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs12896888	chr14:36986388-36986389	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
5	rs374569055	chr14:36986437-36986438	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs12896924	chr14:36986451-36986452	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs201995699	chr14:36986473-36986474	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs143269839	chr14:36986492-36986493	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs566854717	chr14:36986528-36986529	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs371404638	chr14:36986534-36986535	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs548436641	chr14:36986541-36986542	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs568279403	chr14:36986573-36986574	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs537209983	chr14:36986583-36986584	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs556880296	chr14:36986595-36986596	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
15	rs147542347	chr14:36986596-36986597	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
16	rs377417768	chr14:36986627-36986628	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
17	rs200560568	chr14:36986635-36986636	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
18	rs552685896	chr14:36986652-36986653	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs1064922	chr14:36986771-36986772	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs387906404	chr14:36986781-36986782	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs577015120	chr14:36986875-36986876	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs539786671	chr14:36986913-36986914	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs137852694	chr14:36986944-36986945	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs28936671	chr14:36986962-36986963	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs28936672	chr14:36986976-36986977	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs137852692	chr14:36986986-36986987	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs202152277	chr14:36986990-36986991	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs374325397	chr14:36987008-36987009	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
29	rs572484690	chr14:36987038-36987039	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
30	rs137852693	chr14:36987076-36987077	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs199474692	chr14:36987106-36987107	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs3168890	chr14:36987115-36987116	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs562374959	chr14:36987134-36987135	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs575848748	chr14:36987154-36987155	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs61754300	chr14:36987155-36987156	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs201057772	chr14:36987159-36987160	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs370921485	chr14:36987240-36987241	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs372806369	chr14:36987289-36987290	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs566318183	chr14:36987296-36987297	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs547093191	chr14:36987316-36987317	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
41	rs2076736	chr14:36987323-36987324	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
42	rs529251554	chr14:36987344-36987345	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
43	rs549118350	chr14:36987361-36987362	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs568298689	chr14:36987376-36987377	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs45441699	chr14:36987379-36987380	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs371061006	chr14:36987394-36987395	Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs550503645	chr14:36987462-36987463	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs556194204	chr14:36987499-36987500	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs539278496	chr14:36987501-36987502	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs537045708	chr14:36987512-36987513	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Colorectal cancer	16774939	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic myeloid leukemia	20724749	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Wilms tumour	21544195	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Burkitt''s lymphoma	19759907	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21785460	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Lung cancer	17925434	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
abnormal development	18461090	CNVD
Prostate cancer	21298110	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	21858162	CNVD
Lung cancer	20031968	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21183584	CNVD
Prostate cancer	21147910	CNVD

Chromatin state (count:512 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:36981400-36991200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
2	chr14:36984200-36986400	Weak transcription	Pancreas	Pancrea
3	chr14:36985400-36988200	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
4	chr14:36985600-36986400	Active TSS	Lung	lung
5	chr14:36985800-36986400	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
6	chr14:36986200-36987000	Bivalent/Poised TSS	Brain Germinal Matrix	brain
7	chr14:36986400-36986600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
8	chr14:36986400-36986600	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
9	chr14:36986400-36986600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr14:36986400-36986600	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
11	chr14:36986400-36986600	Bivalent Enhancer	Fetal Intestine Large	intestine
12	chr14:36986400-36986600	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
13	chr14:36986400-36986600	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
14	chr14:36986400-36986600	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
15	chr14:36986400-36986600	Bivalent Enhancer	HMEC	breast
16	chr14:36986400-36986800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
17	chr14:36986400-36986800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr14:36986400-36986800	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain
19	chr14:36986400-36986800	Bivalent Enhancer	Left Ventricle	heart
20	chr14:36986400-36986800	Transcr. at gene 5' and 3'	Lung	lung
21	chr14:36986400-36986800	Flanking Bivalent TSS/Enh	Right Ventricle	heart
22	chr14:36986400-36987000	Flanking Bivalent TSS/Enh	Psoas Muscle	Psoas
23	chr14:36986400-36987000	Bivalent/Poised TSS	Right Atrium	heart
24	chr14:36986400-36987200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
25	chr14:36986400-36987200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr14:36986400-36987600	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr14:36986400-36988200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
28	chr14:36986400-36988200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr14:36986400-36988200	Bivalent Enhancer	Esophagus	oesophagus
30	chr14:36986400-36988400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
31	chr14:36986400-36988600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
32	chr14:36986400-36989000	Bivalent Enhancer	Liver	Liver
33	chr14:36986400-36989200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr14:36986400-36989800	Enhancers	Gastric	stomach
35	chr14:36986400-36989800	Enhancers	Pancreas	Pancrea
36	chr14:36986600-36986800	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
37	chr14:36986600-36986800	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
38	chr14:36986600-36987000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
39	chr14:36986600-36987000	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
40	chr14:36986600-36987000	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
41	chr14:36986600-36987200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr14:36986600-36987200	Bivalent Enhancer	Stomach Smooth Muscle	stomach
43	chr14:36986600-36987400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
44	chr14:36986600-36988200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
45	chr14:36986600-36988200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
46	chr14:36986600-36989400	Bivalent Enhancer	Spleen	Spleen
47	chr14:36986800-36987000	Flanking Bivalent TSS/Enh	Lung	lung
48	chr14:36986800-36987000	Bivalent Enhancer	Right Ventricle	heart
49	chr14:36987000-36987200	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
50	chr14:36987000-36987200	Bivalent Enhancer	Brain Angular Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links